Business Context and Reporting Period
Inflection Point Acquisition Corp. V (IPEX), a Cayman Islands exempted company and emerging growth company, filed this Form 8-K on July 13, 2026. The filing reports the entry into a Second Amendment to the Business Combination Agreement originally signed on October 13, 2025, with GOWell Technology Limited (GOWell). IPEX is currently in the process of a proposed business combination with GOWell, with a preliminary proxy statement/prospectus filed with the SEC.
Key Financial Metrics
This filing does not contain audited financial statements, revenue, profit, cash flow, or liquidity metrics for IPEX or GOWell. The only specific financial figures disclosed relate to transaction expense caps:
- SPAC Transaction Expenses Cap: Increased from $8,000,000 to $9,000,000.
- Earnout Structure: Adjusted to allow partial earnout achievement at 80% of the 2026 EBITDA Target, in addition to the existing 90% threshold.
Material Changes Versus Prior Period
The material change reported is the execution of the Second Amendment to the Business Combination Agreement on July 13, 2026. Key modifications include:
- Earnout Thresholds: The amendment introduces a new tier for the 2026 EBITDA earnout, allowing partial payment at 80% achievement of the target. This aligns the 2026 structure with the existing earnout structures for the 2027 and 2028 EBITDA Targets.
- Expense Cap Increase: The maximum allowable SPAC Transaction Expenses were raised by $1,000,000 to $9,000,000.
- Expense Carve-outs: Certain specified expenses are now excluded from the $9,000,000 cap.
Guidance, Outlook, and Risks
Outlook and Management Commentary: The company is proceeding toward shareholder voting on the Business Combination. A definitive proxy statement/prospectus will be mailed to shareholders once the registration statement is declared effective. The filing emphasizes that the amendment is intended to refine the earnout mechanics and expense allowances.
Risks and Contingencies: The filing includes standard disclaimers that the report is for informational purposes only and does not constitute an offer to sell securities or a solicitation of votes. The final terms of the transaction remain subject to shareholder approval and regulatory effectiveness.
Important Facts for Investor Verification
- Verify the full text of the Second Amendment (Exhibit 2.1) to understand the specific expenses carved out from the $9,000,000 cap.
- Review the preliminary proxy statement/prospectus for detailed financial projections of GOWell and the specific EBITDA targets for 2026, 2027, and 2028.
- Confirm the record date for shareholder voting on the Business Combination once announced.
- Monitor the status of the registration statement effectiveness to determine when the definitive proxy statement will be distributed.